Literature DB >> 29084740

Complement activation: an atypical presentation of an atypical syndrome.

Alfredo Iardino1, Viviane Bunin2, Luan D Truong3, Hector Alejandro Preti4.   

Abstract

A 42-year-old Hispanic female and long-distance runner was seen for evaluation of fatigue. Her physical examination showed petechiae and ecchymoses in upper extremities, abdominal distension and bilateral ankle oedema. Laboratory workup revealed anaemia, thrombocytopenia, hypoalbuminemia and proteinuria of 1.4 g/24 hours. No schistocytes were found on peripheral blood smear. CT of her abdomen revealed diffuse small lymphadenopathy and hepatomegaly. Bone marrow biopsy demonstrated normal trilineage hematopoiesis with no hemophagocytosis. The patient was started on oral prednisone with no improvement and was subsequently admitted to the hospital for pulsed steroids, intravenous immunoglobulin and rituximab. Her proteinuria became nephrotic range, and a renal biopsy revealed features of thrombotic microangiopathy limited to the glomerular capillaries. ADAMTS13 was low which is >10% of normal, and a diagnosis of atypical haemolytic-uraemic syndrome (aHUS) was made. Eculizumab was started with prompt response. Whole exome sequencing demonstrated mutation in SPTA1, which has been associated with red blood cell membrane diseases but has not been described in patients with aHUS. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  acute renal failure; haematology (drugs and medicines); malignant and benign haematology; nephrotic syndrome; proteinurea

Mesh:

Year:  2017        PMID: 29084740      PMCID: PMC5665199          DOI: 10.1136/bcr-2017-221798

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Atypical hemolytic-uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

Review 2.  Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.

Authors:  Jeffrey Laurence
Journal:  Clin Adv Hematol Oncol       Date:  2012-10

3.  Malignancy and thrombotic microangiopathy or atypical haemolytic and uraemic syndrome?

Authors:  Guillaume A Favre; Maxime Touzot; Véronique Fremeaux-Bacchi; Hervé Hyvernat; Jean-Pierre Gueffet; Pierre S Rohrlich; Viviane Queyrel; Vincent Esnault; Fadi Fakhouri
Journal:  Br J Haematol       Date:  2014-04-21       Impact factor: 6.998

4.  Autoimmune-type atypical hemolytic uremic syndrome treated with eculizumab as first-line therapy.

Authors:  Masataka Hisano; Akira Ashida; Eiji Nakano; Mamiko Suehiro; Yoko Yoshida; Masanori Matsumoto; Toshiyuki Miyata; Yoshihiro Fujimura; Motoshi Hattori
Journal:  Pediatr Int       Date:  2015-04       Impact factor: 1.524

Review 5.  Management of cancer-associated thrombotic microangiopathy: what is the right approach?

Authors:  Theresa L Werner; Neeraj Agarwal; Heather M Carney; George M Rodgers
Journal:  Am J Hematol       Date:  2007-04       Impact factor: 10.047

6.  Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome.

Authors:  Elizabeth C Schramm; Lubka T Roumenina; Tania Rybkine; Sophie Chauvet; Paula Vieira-Martins; Christophe Hue; Tara Maga; Elisabetta Valoti; Valerie Wilson; Sakari Jokiranta; Richard J H Smith; Marina Noris; Tim Goodship; John P Atkinson; Veronique Fremeaux-Bacchi
Journal:  Blood       Date:  2015-01-21       Impact factor: 22.113

Review 7.  Thrombotic thrombocytopenic purpura.

Authors:  B Lämmle; J A Kremer Hovinga; L Alberio
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

8.  High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

Authors:  Fengxiao Bu; Nicolo Ghiringhelli Borsa; Michael B Jones; Erika Takanami; Carla Nishimura; Jill J Hauer; Hela Azaiez; Elizabeth A Black-Ziegelbein; Nicole C Meyer; Diana L Kolbe; Yingyue Li; Kathy Frees; Michael J Schnieders; Christie Thomas; Carla Nester; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2015-08-17       Impact factor: 10.121

9.  A case of atypical hemolytic uremic syndrome.

Authors:  Mohammad Amin Fallahzadeh; Mohammad Kazem Fallahzadeh; Ali Derakhshan; Eslam Shorafa; Yusof Mojtahedi; Bita Geramizadeh; Mohammad Hossein Fallahzadeh
Journal:  Iran J Kidney Dis       Date:  2014-07       Impact factor: 0.892

Review 10.  The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome.

Authors:  Cristina Rosário; Gisele Zandman-Goddard; Esther G Meyron-Holtz; David P D'Cruz; Yehuda Shoenfeld
Journal:  BMC Med       Date:  2013-08-22       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.